Intelligence Briefing
Founded insitro in 2018 to transform drug discovery using machine learning, raising $643M at a $2.8B valuation (Series D, September 2024). Co-founded Coursera, reaching 100M+ learners globally. MacArthur Fellow (2004) and member of the National Academy of Sciences. Named among Forbes' Greatest Innovators in 2025.
BSc, Computer Science — Hebrew University of Jerusalem
MSc, Computer Science — Hebrew University of Jerusalem
PhD, Computer Science — Stanford University
Operational History
Current Role
Continuing as Founder & CEO of insitro, focusing on AI-driven drug discovery.
careerForbes' Greatest Innovators
Named among Forbes' Greatest Innovators for contributions to AI and drug discovery.
awardFounded insitro
Founded insitro to leverage machine learning for drug discovery.
foundingCo-founding Coursera
Co-founded Coursera, an online learning platform, which has reached over 100 million learners worldwide.
foundingMacArthur Fellowship
Awarded the MacArthur Fellowship for contributions to computer science and education.
awardAGI Position Assessment
Unknown
Optimistic about AI's transformative potential in science and healthcare. Believes responsible deployment requires domain expertise and rigorous validation. Advocates for AI as a tool to augment human capabilities rather than replace them, emphasizing collaboration between humans and machines.
Optimistic about AI's transformative potential in science and healthcare. Believes responsible deployment requires domain expertise and rigorous validation. Advocates for AI as a tool to augment human capabilities rather than replace them, emphasizing collaboration between humans and machines.
Intercepted Communications
“AI has the potential to revolutionize the way we approach drug discovery and healthcare.”
“The collaboration between humans and machines will define the future of scientific research.”
“Responsible AI deployment requires rigorous validation and domain expertise.”
“We must leverage AI to augment human capabilities, not replace them.”
“The future of drug discovery lies in the integration of machine learning and biological insights.”
Research Output
Advancements in Drug Discovery through Machine Learning
2026A forthcoming paper on the latest advancements in drug discovery.
AI in Healthcare: Opportunities and Challenges
2025Analyzes the role of AI in transforming healthcare.
Multi-task Learning for Drug Discovery
2018Explores the application of multi-task learning in drug discovery.
Coursera: A New Model for Higher Education
2013Communications of the ACM
Discusses the impact of Coursera on education.
Bayesian Network Structure Learning
2010Research on algorithms for learning the structure of Bayesian networks.
Probabilistic Graphical Models
2009Cambridge University Press
A comprehensive textbook on probabilistic graphical models.
Field Intelligence
The Future of AI in Drug Discovery
AI and Ethics: A Conversation
Innovations in Machine Learning
Known Associates
Andrew Ng
collaboratorCo-founder of Coursera and prominent figure in AI education.
View Dossier →Jeffrey Dean
collaboratorSenior Fellow at Google and collaborator on AI research.
View Dossier →Fei-Fei Li
collaboratorAI researcher and advocate for ethical AI, known for her work in computer vision.
View Dossier →Demis Hassabis
collaboratorCo-founder and CEO of DeepMind, known for advancements in AI research.
View Dossier →Organizational Affiliations
Current
insitro
Founder & CEO
2018 - Present
Former
Coursera
Co-founder & Co-CEO
2012 - 2018
Calico
Chief Computing Officer
2015 - 2017
Commendations
2025
Forbes' Greatest Innovators
Forbes
Honored for significant contributions to AI and drug discovery.
2004
MacArthur Fellowship
MacArthur Foundation
Recognized for exceptional creativity in scientific research and education.
Source Material
Dossier last updated: 2026-03-04